-
1
-
-
78751499845
-
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: Retrospective analysis of monkey as a single species for first-in-human prediction
-
Dong JQ, Salinger DH, Endres CJ, Gibbs JP, Hsu CP, Stouch BJ, Hurh E, and Gibbs MA (2011) Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction. Clin Pharmacokinet 50:131-142.
-
(2011)
Clin Pharmacokinet
, vol.50
, pp. 131-142
-
-
Dong, J.Q.1
Salinger, D.H.2
Endres, C.J.3
Gibbs, J.P.4
Hsu, C.P.5
Stouch, B.J.6
Hurh, E.7
Gibbs, M.A.8
-
2
-
-
73449088412
-
Physiologically based pharmacokinetics (PBPK)
-
Espié P, Tytgat D, Sargentini-Maier ML, Poggesi I, and Watelet JB (2009) Physiologically based pharmacokinetics (PBPK). Drug Metab Rev 41:391-407.
-
(2009)
Drug Metab Rev
, vol.41
, pp. 391-407
-
-
Espié, P.1
Tytgat, D.2
Sargentini-Maier, M.L.3
Poggesi, I.4
Watelet, J.B.5
-
3
-
-
58149230979
-
TGF-beta signaling in vascular biology and dysfunction
-
Goumans MJ, Liu Z, and ten Dijke P (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19:116-127.
-
(2009)
Cell Res
, vol.19
, pp. 116-127
-
-
Goumans, M.J.1
Liu, Z.2
Ten Dijke, P.3
-
4
-
-
65449166750
-
Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches
-
Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, Webster R, et al. (2009) Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol 49:513-533.
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 513-533
-
-
Hosea, N.A.1
Collard, W.T.2
Cole, S.3
Maurer, T.S.4
Fang, R.X.5
Jones, H.6
Kakar, S.M.7
Nakai, Y.8
Smith, B.J.9
Webster, R.10
-
5
-
-
79951828866
-
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies
-
Hu-Lowe DD, Chen E, Zhang L, Watson KD, Mancuso P, Lappin P, Wickman G, Chen JH, Wang J, Jiang X, et al. (2011) Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Res 71:1362-1373.
-
(2011)
Cancer Res
, vol.71
, pp. 1362-1373
-
-
Hu-Lowe, D.D.1
Chen, E.2
Zhang, L.3
Watson, K.D.4
Mancuso, P.5
Lappin, P.6
Wickman, G.7
Chen, J.H.8
Wang, J.9
Jiang, X.10
-
6
-
-
0003633755
-
-
Institute of Laboratory Animal Resources 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC
-
Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
-
(1996)
Guide for the Care and Use of Laboratory Animals
-
-
-
7
-
-
0036900286
-
Antibody discovery: The use of transgenic mice to generate human monoclonal antibodies for therapeutics
-
Kellermann SA and Green LL (2002) Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics. Curr Opin Biotechnol 13:593-597.
-
(2002)
Curr Opin Biotechnol
, vol.13
, pp. 593-597
-
-
Kellermann, S.A.1
Green, L.L.2
-
8
-
-
71449090902
-
Interspecies scaling of therapeutic monoclonal antibodies: Initial look
-
Ling J, Zhou H, Jiao Q, and Davis HM (2009) Interspecies scaling of therapeutic monoclonal antibodies: initial look. J Clin Pharmacol 49:1382-1402.
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 1382-1402
-
-
Ling, J.1
Zhou, H.2
Jiao, Q.3
Davis, H.M.4
-
9
-
-
0033537831
-
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1
-
Lux A, Attisano L, and Marchuk DA (1999) Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274:9984-9992.
-
(1999)
J Biol Chem
, vol.274
, pp. 9984-9992
-
-
Lux, A.1
Attisano, L.2
Marchuk, D.A.3
-
10
-
-
33746998477
-
ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression
-
Lux A, Salway F, Dressman HK, Kröner-Lux G, Hafner M, Day PJ, Marchuk DA, and Garland J (2006) ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 6:13.
-
(2006)
BMC Cardiovasc Disord
, vol.6
, pp. 13
-
-
Lux, A.1
Salway, F.2
Dressman, H.K.3
Kröner-Lux, G.4
Hafner, M.5
Day, P.J.6
Marchuk, D.A.7
Garland, J.8
-
11
-
-
0035730322
-
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition
-
DOI 10.1023/A:1014414520282
-
Mager DE and Jusko WJ (2001) General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Pharmacodyn 28:507-532. (Pubitemid 34289541)
-
(2001)
Journal of Pharmacokinetics and Pharmacodynamics
, vol.28
, Issue.6
, pp. 507-532
-
-
Mager, D.E.1
Jusko, W.J.2
-
12
-
-
0038679559
-
Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-β1a in monkeys
-
DOI 10.1124/jpet.103.049502
-
Mager DE, Neuteboom B, Efthymiopoulos C, Munafo A, and Jusko WJ (2003) Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-beta1a in monkeys. J Pharmacol Exp Ther 306:262-270. (Pubitemid 36734381)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.306
, Issue.1
, pp. 262-270
-
-
Mager, D.E.1
Neuteboom, B.2
Efthymiopoulos, C.3
Munafo, A.4
Jusko, W.J.5
-
13
-
-
0032700670
-
Allometric issues in drug development
-
Mahmood I (1999a) Allometric issues in drug development. J Pharm Sci 88:1101-1106.
-
(1999)
J Pharm Sci
, vol.88
, pp. 1101-1106
-
-
Mahmood, I.1
-
14
-
-
0032822442
-
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: A comparative study
-
Mahmood I (1999b) Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. J Pharm Pharmacol 51:905-910.
-
(1999)
J Pharm Pharmacol
, vol.51
, pp. 905-910
-
-
Mahmood, I.1
-
15
-
-
69949109408
-
Pharmacokinetic allometric scaling of antibodies: Application to the first-in-human dose estimation
-
Mahmood I (2009) Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation. J Pharm Sci 98:3850-3861.
-
(2009)
J Pharm Sci
, vol.98
, pp. 3850-3861
-
-
Mahmood, I.1
-
16
-
-
23744475396
-
Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
-
DOI 10.1007/s11095-005-5642-4
-
Ng CM, Joshi A, Dedrick RL, Garovoy MR, and Bauer RJ (2005) Pharmacokineticpharmacodynamic- efficacy analysis of efalizumab in patients with moderate to severe psoriasis. Pharm Res 22:1088-1100. (Pubitemid 41127066)
-
(2005)
Pharmaceutical Research
, vol.22
, Issue.7
, pp. 1088-1100
-
-
Ng, C.M.1
Joshi, A.2
Dedrick, R.L.3
Garovoy, M.R.4
Bauer, R.J.5
-
17
-
-
12944273545
-
Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
-
DOI 10.1073/pnas.97.6.2626
-
Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626-2631. (Pubitemid 30159221)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.6
, pp. 2626-2631
-
-
Oh, S.P.1
Seki, T.2
Goss, K.A.3
Imamura, T.4
Yi, Y.5
Donahoe, P.K.6
Li, L.7
Miyazono, K.8
Ten, D.P.9
Kim, S.10
Li, E.11
-
18
-
-
70349260659
-
Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells
-
Shao ES, Lin L, Yao Y, and Boström KI (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114:2197-2206.
-
(2009)
Blood
, vol.114
, pp. 2197-2206
-
-
Shao, E.S.1
Lin, L.2
Yao, Y.3
Boström, K.I.4
-
19
-
-
77955297665
-
Prediction of human clearance of therapeutic proteins: Simple allometric scaling method revisited
-
Wang W and Prueksaritanont T (2010) Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Biopharm Drug Dispos 31:253-263.
-
(2010)
Biopharm Drug Dispos
, vol.31
, pp. 253-263
-
-
Wang, W.1
Prueksaritanont, T.2
|